Bempedoic acid
Esperion
['cardio']
late breaking at #acc23/#wccardio: in the clear outcomes trial, statin-intolerant patients with, or at high risk for, cvd received bempedoic acid or placebo. bempedoic acid reduced ldl cholesterol and the risk of cardiovascular events. full trial results: 
The New England Journal of Medicine (https://t.co/YGfDrRsIhE) is the world’s leading medical journal and website.